Nuclear Hormone Receptors

Nuclear hormone receptors are ligand-activated transcription factors that bind small lipophilic signaling molecules — steroid and thyroid hormones, retinoids, vitamin D, and certain metabolites — and directly regulate gene transcription. Because their ligands cross the plasma membrane, these receptors are typically cytoplasmic or nuclear rather than cell surface proteins, and they provide an instructive contrast to membrane receptors within the broader receptor landscape.

Definition

A nuclear hormone receptor is a ligand-activated transcription factor that binds a small lipophilic ligand and, through a conserved DNA-binding and ligand-binding domain architecture, regulates the transcription of specific target genes.

Scope

The entry covers the modular domain organization of nuclear receptors, the nature of their lipophilic ligands, the mechanism by which ligand binding switches the receptor between repressive and activating states on DNA, and the family's role as a unified superfamily of transcriptional regulators. It is a biochemical reference topic and provides no clinical guidance.

Core questions

• What kinds of ligands activate nuclear receptors, and why are they intracellular?
• How is a nuclear receptor organized into functional domains?
• How does ligand binding switch a receptor from gene repression to activation?
• How does the superfamily unify diverse hormonal and metabolic signals?

Key concepts

• Lipophilic, membrane-permeant ligands
• Ligand-activated transcription factor
• DNA-binding domain and hormone-response elements
• Ligand-binding domain
• Coactivator and corepressor exchange
• Steroid, thyroid, and retinoid receptors
• Orphan receptors

Key theories

Nuclear receptor superfamily concept

Steroid, thyroid, retinoid, and related receptors share a common modular architecture and evolutionary origin, forming a single superfamily of ligand-activated transcription factors that translate diverse lipophilic signals into changes in gene expression.

Mechanisms

Nuclear receptors share a modular structure with a variable N-terminal region, a highly conserved DNA-binding domain that recognizes specific hormone-response elements, and a C-terminal ligand-binding domain. Their ligands are small and lipophilic, allowing them to cross the plasma membrane and reach intracellular receptors. In the absence of ligand, many receptors are held in an inactive state, in some cases bound to corepressor complexes or sequestered by chaperones; ligand binding induces a conformational change in the ligand-binding domain that releases corepressors and recruits coactivators, switching the receptor toward transcriptional activation of target genes. Some family members act as homodimers and others as heterodimers, and a subset are orphan receptors for which a physiological ligand is uncertain or absent.

Clinical relevance

Nuclear receptors mediate the actions of steroid and thyroid hormones, vitamin D, and retinoids, and they are targets of widely used drug classes; their dysregulation contributes to endocrine, metabolic, and proliferative disorders. This entry describes their molecular biology and is not a basis for diagnosis or treatment.

History

Cloning of the glucocorticoid and estrogen receptors in the mid-1980s revealed a shared domain architecture, leading Ronald Evans to articulate the steroid and thyroid hormone receptor superfamily in 1988. The subsequent decade expanded the family to include retinoid, vitamin D, and numerous orphan receptors and clarified the coactivator-corepressor exchange that underlies ligand-dependent transcriptional switching, prompting a unifying nomenclature.

Key figures

• Ronald Evans
• Pierre Chambon
• David Mangelsdorf
• Vincent Laudet

Seminal works

• evans-1988
• mangelsdorf-1995
• germain-2006

Frequently asked questions

Why are nuclear receptors not on the cell surface like most receptors?

Their ligands are small lipophilic molecules that can pass through the plasma membrane, so the receptor can reside in the cytoplasm or nucleus and act directly on DNA once it binds its ligand.

What does it mean to call a nuclear receptor a transcription factor?

Once activated by its ligand, the receptor binds specific DNA sequences and recruits the machinery that turns target genes on or off, so the receptor itself directly controls gene expression.